Conjugal transfer of an R-plasmid in Pasteurella multocida.

Antimicrobial Agents and Chemotherapy
D C HirshK R Rhoades

Abstract

A strain of Pasteurella multocida isolated from turkeys during an outbreak of septicemic disease (fowl cholera) was shown to possess the ability to transfer streptomycin and sulphadiazine resistance to P. multocida and to Escherichia coli by conjugation. The genes necessary for the transfer of the resistance genes appeared to be associated with a plasmid of molecular weight 28.5 x 10(6). The resistance genes were shown to be associated with a second plasmid of molecular weight 7.2 x 10(6).

References

Jul 1, 1979·Plasmid·R P SilverC A Hjerpe
Sep 1, 1978·Antimicrobial Agents and Chemotherapy·S M Berman, D C Hirsh
Aug 1, 1975·Infection and Immunity·L P ElwellS Falkow
Sep 11, 1975·The Journal of Infectious Diseases·G M Thorne, W E Farrar
Aug 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·S N CohenL Hsu
Feb 1, 1974·Journal of Bacteriology·P GuerryS Falkow
Mar 1, 1952·Journal of Bacteriology·J LEDERBERG, E M LEDERBERG

❮ Previous
Next ❯

Citations

Sep 1, 1995·Veterinary Microbiology·I S DialloP B Spradbrow
Mar 4, 2000·Veterinary Microbiology·M L HuntK M Townsend
Jun 17, 2011·Animal Health Research Reviews·S B ShivachandraA A Kumar
Jan 1, 1990·Microbiology and Immunology·J YamamotoM Shimizu
Aug 1, 1988·Antimicrobial Agents and Chemotherapy·V O LivrelliJ L Martel
May 1, 1989·Antimicrobial Agents and Chemotherapy·D C HirshR H McCapes
Dec 27, 2002·The Journal of General and Applied Microbiology·Muthafar Hussain Al-HaddawiAbdul Rahman Sheikh-Omar
Jul 5, 2013·Clinical Microbiology Reviews·Brenda A Wilson, Mengfei Ho
Jan 1, 1992·Microbial Pathogenesis·L JablonskiG R Carter
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Corinna KehrenbergStefan Schwarz
Oct 3, 2001·Nucleosides, Nucleotides & Nucleic Acids·A CiureaA Kirn
Jun 20, 2018·Microbiology Spectrum·Geovana B MichaelStefan Schwarz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.